Mathis Simon, Putzer Gabriel, Gasteiger Lukas, Eschertzhuber Stephan, Schneeberger Stefan, Cardini Benno, Hell Tobias, Martini Judith
Department of Anaesthesiology and Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria.
Department of Anaesthesiology and Intensive Care Medicine, Hospital Hall in Tirol, Austria.
Transplant Direct. 2024 May 15;10(6):e1628. doi: 10.1097/TXD.0000000000001628. eCollection 2024 Jun.
Normothermic machine perfusion (NMP) of liver grafts has been shown to reduce intraoperative catecholamine consumption and the need for allogenic blood products after reperfusion compared with organs undergoing classical static cold storage (SCS). This study aimed to investigate the effects of an NMP phase after SCS (NMP after SCS) of liver grafts in terms of postreperfusion hemodynamics and transfusion requirements.
Eighteen recipients of NMP after SCS grafts were matched according to recipient age, donor age, and model for end-stage liver disease score in a 1:2 ratio with recipients of an SCS graft. Postreperfusion hemodynamics and the need for catecholamines, blood products, and clotting factors were compared.
After reperfusion of the organ, patients in the NMP after SCS group showed significantly reduced transfusion requirements for packed red blood cells and platelet concentrates compared with patients of the SCS group ( < 0.001 and = 0.018, respectively). In addition, patients in the NMP after SCS group received less fibrinogen concentrate (NMP after SCS group 0 [0-1.5] g versus SCS group 2 [0-4] g; = 0.0163). No differences in postreperfusion hemodynamics could be detected between groups.
This retrospective analysis shows that NMP reduces postreperfusion requirements of red blood cells, platelet concentrates, and fibrinogen concentrate even if installed after a phase of organ SCS, because it may be practiced on most centers where NMP is available.
与接受传统静态冷藏(SCS)的器官相比,肝移植的常温机器灌注(NMP)已被证明可减少术中儿茶酚胺的消耗量以及再灌注后对异体血制品的需求。本研究旨在探讨肝移植在SCS后进行NMP阶段(SCS后NMP)对再灌注后血流动力学和输血需求的影响。
18例接受SCS后NMP移植的受者,按照受者年龄、供者年龄和终末期肝病模型评分,以1:2的比例与接受SCS移植的受者进行匹配。比较再灌注后的血流动力学以及对儿茶酚胺、血制品和凝血因子的需求。
器官再灌注后,SCS后NMP组患者的浓缩红细胞和血小板浓缩物的输血需求量与SCS组患者相比显著降低(分别为<0.001和=0.018)。此外,SCS后NMP组患者接受的纤维蛋白原浓缩物较少(SCS后NMP组0[0-1.5]g,SCS组2[0-4]g;=0.0163)。两组之间在再灌注后血流动力学方面未检测到差异。
这项回顾性分析表明,即使在器官SCS阶段后进行NMP,NMP也能降低再灌注后对红细胞、血小板浓缩物和纤维蛋白原浓缩物的需求,因为在大多数具备NMP条件的中心都可以实施。